Zevra Therapeutics Inc — Dividend History & Yield (NASDAQ:ZVRA) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

ニュース

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

Neil F. McFarlane, presidente di Zevra Therapeutics, vende azioni per 125mila dollari

Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares

Il CMO di Zevra Therapeutics Quartel vende azioni per 40.000 dollari

Joshua Schafer, CCO di Zevra, vende azioni ZVRA per $29.800

Zevra Therapeutics CMO Quartel sells $40k in shares

Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock

Il CEO di Zevra Therapeutics McFarlane vende azioni per 853 mila dollari

Zevra Therapeutics CEO McFarlane sells $853k in shares

Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)